About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

First Generic Version of Lexapro permitted by US

by Medindia Content Team on May 23, 2006 at 8:13 PM
Font : A-A+

First Generic Version of Lexapro permitted by US

The first generic version of Forest Laboratories Inc.'s antidepressant Lexapro permitted by Food and Drug Administration, U.S.

An application from Teva Pharmaceutical Industries Ltd. Was allowed by FDA to sell escitalopram, a generic immitator of the oral drug as per Reuters.

Advertisement

Complete rights on the drug are retained by the Forest Labs till March 2012 and Teva has been sued for violation in the court. This copyright is illogical as per Teva.

Lundbeck, a Danish pharmaceutical whose sales in the latest quarter were $464 million accepts royalties of Lexpro sold in U.S.
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Monkeypox Outbreak: What it is, How Does it Spread & the Prevention
Seasonal Allergy Medications
How to Choose the Best Eczema-Friendly Moisturizer for Children?
View all
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

Most Popular on Medindia

Pregnancy Confirmation Calculator Post-Nasal Drip Daily Calorie Requirements Drug Side Effects Calculator Find a Hospital Indian Medical Journals Find a Doctor Blood Donation - Recipients Loram (2 mg) (Lorazepam) Selfie Addiction Calculator

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use